Current investigation of carcinoembryonic antigen cell adhesion molecule (CEACAM) biology summary of the 32nd CEA symposium: 20-23 September 2024. Würzburg, Germany.

Publisher: Wiley Country of Publication: England NLM ID: 0245331 Publication Model: Print Cited Medium: Internet ISSN: 1365-2362 (Electronic) Linking ISSN: 00142972 NLM ISO Abbreviation: Eur J Clin Invest Subsets: In Process; MEDLINE

Publication: Oxford : Wiley
Original Publication: Berlin, New York, Springer-Verlag, on behalf of the European Society for Clinical Investigation.

Zhuo Y, Yang JY, Moremen KW, Prestegard JH. Glycosylation alters dimerization properties of a cell‐surface signaling protein, Carcinoembryonic Antigen‐related Cell Adhesion Molecule 1 (CEACAM1). J Biol Chem. 2016;291(38):20085‐20095.
Tchoupa AK, Schuhmacher T, Hauck CR. Signaling by epithelial members of the CEACAM family—mucosal docking sites for pathogenic bacteria. Cell Commun Signal. 2014;12:27.
Abou‐Rjaily GA, Lee SJ, May D, et al. CEACAM1 modulates epidermal growth factor receptor–mediated cell proliferation. J Clin Invest. 2004;114(7):944‐952.
Poy MN, Ruch RJ, Fernstrom MA, Okabayashi Y, Najjar SM. Shc and CEACAM1 interact to regulate the mitogenic action of insulin. J Biol Chem. 2002;277(2):1076‐1084.
Schmitter T, Agerer F, Peterson L, Munzner P, Hauck CR. Granulocyte CEACAM3 is a phagocytic receptor of the innate immune system that mediates recognition and elimination of human‐specific pathogens. J Exp Med. 2004;199(1):35‐46.
Gray‐Owen SD, Dehio C, Haude A, Grunert F, Meyer TF. CD66 carcinoembryonic antigens mediate interactions between Opa‐expressing Neisseria gonorrhoeae and human polymorphonuclear phagocytes. EMBO J. 1997;16(12):3435‐3445.
Gray‐Owen SD, Blumberg RS. CEACAM1: contact‐dependent control of immunity. Nat Rev Immunol. 2006;6(6):433‐446.
Singer BB, Scheffrahn I, Kammerer R, Suttorp N, Ergun S, Slevogt H. Deregulation of the CEACAM expression pattern causes undifferentiated cell growth in human lung adenocarcinoma cells. PLoS One. 2010;5(1):e8747.
Kilic N, Oliveira‐Ferrer L, Wurmbach JH, et al. Pro‐angiogenic signaling by the endothelial presence of CEACAM1. J Biol Chem. 2005;280(3):2361‐2369.
Adrian J, Bonsignore P, Hammer S, Frickey T, Hauck CR. Adaptation to host‐specific bacterial pathogens drives rapid evolution of a human innate immune receptor. Curr Biol. 2019;29(4):616‐630.
Berger CN, Billker O, Meyer TF, Servin AL, Kansau I. Differential recognition of members of the carcinoembryonic antigen family by Afa/Dr. adhesins of diffusely adhering Escherichia coli (Afa/Dr. DAEC). Mol Microbiol. 2004;52(4):963‐983.
Sheikh A, Fleckenstein JM. Interactions of pathogenic Escherichia coli with CEACAMs. Front Immunol. 2023;14:1120331.
Sheikh A, Tumala B, Vickers TJ, et al. CEACAMs serve as toxin‐stimulated receptors for enterotoxigenic Escherichia coli. Proc Natl Acad Sci USA. 2020;117(46):29055‐29062.
Catton EA, Bonsor DA, Herrera C, et al. Human CEACAM1 is targeted by a streptococcus pyogenes adhesin implicated in puerperal sepsis pathogenesis. Nat Commun. 2023;14(1):2275.
van Sorge NM, Bonsor DA, Deng L, et al. Bacterial protein domains with a novel Ig‐like fold target human CEACAM receptors. EMBO J. 2021;40(7):e106103.
Virji M, Makepeace K, Ferguson DJ, Watt SM. Carcinoembryonic antigens (CD66) on epithelial cells and neutrophils are receptors for Opa proteins of pathogenic neisseriae. Mol Microbiol. 1996;22(5):941‐950.
Muenzner P, Naumann M, Meyer TF, Gray‐Owen SD. Pathogenic Neisseria trigger expression of their carcinoembryonic antigen‐related cellular adhesion molecule 1 (CEACAM1; previously CD66a) receptor on primary endothelial cells by activating the immediate early response transcription factor, nuclear factor‐kappaB. J Biol Chem. 2001;276(26):24331‐24340.
Koniger V, Holsten L, Harrison U, et al. Helicobacter pylori exploits human CEACAMs via HopQ for adherence and translocation of CagA. Nat Microbiol. 2016;2:16188.
Tchoupa AK, Lichtenegger S, Reidl J, Hauck CR. Outer membrane protein P1 is the CEACAM‐binding adhesin of Haemophilus influenzae. Mol Microbiol. 2015;98(3):440‐455.
Hill DJ, Virji M. A novel cell‐binding mechanism of Moraxella catarrhalis ubiquitous surface protein UspA: specific targeting of the N‐domain of carcinoembryonic antigen‐related cell adhesion molecules by UspA1. Mol Microbiol. 2003;48(1):117‐129.
Galaski J, Shhadeh A, Umana A, et al. Fusobacterium nucleatum CbpF mediates inhibition of T cell function through CEACAM1 activation. Front Cell Infect Microbiol. 2021;11:692544.
Brewer ML, Dymock D, Brady RL, Singer BB, Virji M, Hill DJ. Fusobacterium spp. target human CEACAM1 via the trimeric autotransporter adhesin CbpF. J Oral Microbiol. 2019;11(1):1565043.
Klaile E, Muller MM, Schafer MR, et al. Binding of Candida albicans to human CEACAM1 and CEACAM6 modulates the inflammatory response of intestinal epithelial cells. MBio. 2017;8(2):e02142‐16.
Zimmermann W. Evolution: decoy receptors as unique weapons to fight pathogens. Curr Biol. 2019;29(4):R128‐R130.
Sheikh A, Tumala B, Vickers TJ, et al. Enterotoxigenic Escherichia coli heat‐labile toxin drives enteropathic changes in small intestinal epithelia. Nat Commun. 2022;13(1):6886.
Sheikh A, Ganguli D, Vickers TJ, et al. Host‐derived CEACAM‐laden vesicles engage enterotoxigenic Escherichia coli for elimination and toxin neutralization. Proc Natl Acad Sci USA. 2024;121(38):e2410679121.
Sadarangani M, Pollard AJ, Gray‐Owen SD. Opa proteins and CEACAMs: pathways of immune engagement for pathogenic Neisseria. FEMS Microbiol Rev. 2011;35(3):498‐514.
Conners R, Hill DJ, Borodina E, et al. The Moraxella adhesin UspA1 binds to its human CEACAM1 receptor by a deformable trimeric coiled‐coil. EMBO J. 2008;27(12):1779‐1789.
Javaheri A, Kruse T, Moonens K, et al. Helicobacter pylori adhesin HopQ engages in a virulence‐enhancing interaction with human CEACAMs. Nat Microbiol. 2016;2:16189.
Chen YC, Malfertheiner P, Yu HT, et al. Global prevalence of helicobacter pylori infection and incidence of gastric cancer between 1980 and 2022. Gastroenterology. 2024;166(4):605‐619.
Taxauer K, Hamway Y, Ralser A, et al. Engagement of CEACAM1 by Helicobacterpylori HopQ is important for the activation of non‐canonical NF‐kappaB in gastric epithelial cells. Microorganisms. 2021;9(8):1748.
Poirah ICD, Dixit P, Samal S, et al. Association between CEACAMs and hypoxia defines gastric cancer progression. Paper presented at: proceedings of the American Association for Cancer Research annual meeting. Vol 81; 2021:1988.
Chean J, Chen CJ, Gugiu G, et al. Human CEACAM1‐LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. J Biol Chem. 2021;297(5):101311.
Zaidi S, Asalla S, Muturi HT, et al. Loss of CEACAM1 in hepatocytes causes hepatic fibrosis. Eur J Clin Investig. 2024;54(7):e14177.
Najjar SM, Caprio S, Gastaldelli A. Insulin clearance in health and disease. Annu Rev Physiol. 2023;85:363‐381.
Poy MN, Yang Y, Rezaei K, et al. CEACAM1 regulates insulin clearance in liver. Nat Genet. 2002;30(3):270‐276.
Helal RA, Russo L, Ghadieh HE, et al. Regulation of hepatic fibrosis by carcinoembryonic antigen‐related cell adhesion molecule 1. Metabolism. 2021;121:154801.
Muturi HT, Ghadieh HE, Abdolahipour R, et al. Loss of CEACAM1 in endothelial cells causes hepatic fibrosis. Metabolism. 2023;144:155562.
Muturi HT, Ghadieh HE, Asalla S, et al. Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. Mol Metab. 2024;88:102010.
Nakamura K, Kageyama S, Kaldas FM, et al. Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. J Clin Invest. 2020;130(5):2689‐2704.
Dery KJ, Kojima H, Kageyama S, et al. Alternative splicing of CEACAM1 by hypoxia‐inducible factor‐1α enhances tolerance to hepatic ischemia in mice and humans. Sci Transl Med. 2023;15(707):eadf2059.
Hirao H, Kojima H, Dery KJ, et al. Neutrophil CEACAM1 determines susceptibility to NETosis by regulating the S1PR2/S1PR3 axis in liver transplantation. J Clin Invest. 2023;133(3):e162940.
Kojima H, Kadono K, Hirao H, et al. T cell CEACAM1‐TIM‐3 crosstalk alleviates liver transplant injury in mice and humans. Gastroenterology. 2023;165(5):1233‐1248.
Dery KJ, Kupiec‐Weglinski JW. New insights into ischemia–reperfusion injury signaling pathways in organ transplantation. Curr Opin Organ Transplant. 2022;27(5):424‐433.
Dery KJ, Yao S, Cheng B, Kupiec‐Weglinski JW. New therapeutic concepts against ischemia–reperfusion injury in organ transplantation. Expert Rev Clin Immunol. 2023;1–20:1205‐1224.
Dery KJ, Wong Z, Wei M, Kupiec‐Weglinski JW. Mechanistic insights into alternative gene splicing in oxidative stress and tissue injury. Antioxid Redox Signal. 2023. https://doi.org/10.1089/ars.2023.0437.
Huang YH, Zhu C, Kondo Y, et al. CEACAM1 regulates TIM‐3‐mediated tolerance and exhaustion. Nature. 2015;517(7534):386‐390.
Hirao H, Kojima H, Dery KJ, et al. Neutrophil CEACAM1 determines the susceptibility to NETosis by regulating S1PR2/S1PR3 Axis in liver transplantation: from bench‐to‐bedside. J Clin Invest. 2023;133:e162940.
Valera MC, Parant O, Cenac C, et al. Platelet adhesion and thrombus formation in whole blood at arterial shear rate at the end of pregnancy. Am J Reprod Immunol. 2015;74(6):533‐541.
Bremme KA. Haemostatic changes in pregnancy. Best Pract Res Clin Haematol. 2003;16(2):153‐168.
Moore T, Williams JM, Becerra‐Rodriguez MA, Dunne M, Kammerer R, Dveksler G. Pregnancy‐specific glycoproteins: evolution, expression, functions and disease associations. Reproduction. 2022;163(2):R11‐R23.
Assoian RK, Komoriya A, Meyers CA, Miller DM, Sporn MB. Transforming growth factor‐beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem. 1983;258(11):7155‐7160.
Warren J, Im M, Ballesteros A, et al. Activation of latent transforming growth factor‐beta1, a conserved function for pregnancy‐specific beta 1‐glycoproteins. Mol Hum Reprod. 2018;24(12):602‐612.
Szklanna PB, Parsons ME, Wynne K, et al. The platelet releasate is altered in human pregnancy. Proteomics Clin Appl. 2019;13(3):e1800162.
Yung HW, Zhao X, Glover L, et al. Perturbation of placental protein glycosylation by endoplasmic reticulum stress promotes maladaptation of maternal hepatic glucose metabolism. iScience. 2023;26(1):105911.
Rattila S, Dunk CEE, Im M, et al. Interaction of pregnancy‐specific glycoprotein 1 with integrin Alpha5beta1 is a modulator of extravillous trophoblast functions. Cells. 2019;8(11):1369.
Ghavampour S, Kleefeldt F, Bommel H, et al. Endothelial barrier function is differentially regulated by CEACAM1‐mediated signaling. FASEB J. 2018;32(10):5612‐5625.
Kleefeldt F, Bommel H, Broede B, et al. Aging‐related carcinoembryonic antigen‐related cell adhesion molecule 1 signaling promotes vascular dysfunction. Aging Cell. 2019;18(6):e13025.
Kleefeldt F, Rueckschloss U, Ergun S. CEACAM1 promotes vascular aging processes. Aging (Albany NY). 2020;12(4):3121‐3123.

P30 DK052574 United States DK NIDDK NIH HHS; R01-DK054254 United States DK NIDDK NIH HHS; R01-MD012579 United States DK NIDDK NIH HHS; DFG Si 1558/6-1 Deutsche Forschungsgemeinschaft; R01 AI089894 United States AI NIAID NIH HHS; R01 AI170949 United States AI NIAID NIH HHS; 5I01BX001469-05 U.S. Department of Veterans Affairs; HORIZON-MSCA-2021-SE-01-01 European Commission; Osteopathic Heritage Foundation

Keywords: CEACAM; atherogenesis; cancer; immunity; metabolism; reproduction

Date Created: 20241215 Latest Revision: 20241215

20241216

10.1111/eci.14355

39674873